US Stock MarketDetailed Quotes

TLPH Talphera

Watchlist
  • 1.060
  • +0.174+19.65%
Trading Jul 29 13:56 ET
18.01MMarket Cap-1514P/E (TTM)

Talphera Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Talphera Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 14, 2024

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.16

+78.67%
Analyst Rating

Strong Buy

Jun 30, 2024

Talphera Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 6, 20242023/Q4281.000K / 140.500K--
--2023/Q3117.000K / 131.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 14, 20242024/Q10.000 / 0.000--
Mar 6, 20242023/Q4281.000K / 140.500K--
--2023/Q3117.000K / 131.500K--

Unlock Free Earnings Estimates

Talphera Earnings Reports

  • Talphera | 10-Q: Quarterly report

    May 14 17:06 ET

  • Talphera | 10-K: Annual report

    Mar 6 17:06 ET

  • AcelRx Pharmaceuticals: Q3 2023 Earnings Report

    Nov 14, 2023 06:07 ET

  • AcelRx Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 17:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg